4-AcO-MiPT 4-Acetoxy-N-isopropyl-N-methyltryptamine CAS: 96096-52-5

CAS NO: 96096-52-5
Our products are for experimental study only
4-HO-DET 4-Hydroxy-N-N-diethyltryptamine
Chemical Name: N-METHYL-N-ISOPROPYLTRYPTAMINE(MIPT)
Molecular Formula: C14H20N2
Formula Weight: 216.32
CAS No.: 96096-52-5
Description Review
Description
Our products are for experime


4-AcO-MiPT, also known as 4-Acetoxy-N-isopropyl-N-methyltryptamine, is a synthetic psychedelic substance that belongs to the tryptamine family. It is a prodrug of the psychoactive substance named MiPT or N-methyl-N-isopropyltryptamine. The chemical compound was first synthesized by David E. Nichols in the late 1990s and is a popular recreational drug due to its hallucinatory properties, which produce intense visual and auditory effects.

Chemical name 4-Acetoxy-N-isopropyl-N-methyltryptamine

Molecular formula C14H20N2O2

Formula weight 248.3 g/mol

CAS No 96096-52-5

Top ten keywords and synonyms from Google:

  1. Psychedelic substance
  2. Tryptamine
  3. Prodrug
  4. Hallucinatory effects
  5. Recreational drug
  6. Serotonin agonist
  7. Nitrogen heterocyclic compound
  8. MiPT
  9. 4-AcO-MiPT hydrochloride
  10. Entheogenic compound

Health benefits of this product: There is no scientific evidence of health benefits of 4-AcO-MiPT, but some users claim it has therapeutic value. It may act as a mood enhancer and relieve symptoms of anxiety or depression. However, it is advisable to seek professional medical help as self-medication can be dangerous.

Potential effects: The onset of 4-AcO-MiPT is typically 20-30 minutes, and the duration of the effects can last up to six hours or longer. The potential effects of this substance may vary from person to person, and the dosage is a significant factor. However, some general effects of 4-AcO-MiPT are:

  1. Hallucinations
  2. Visual and auditory distortions
  3. Feelings of emotional warmth
  4. Intensified colors
  5. Changes in perception of time
  6. Increased empathy
  7. Sense of unity with the universe
  8. Heightened creativity
  9. Spiritual or mystical experiences
  10. Improved mood

Product mechanism: The mechanism of 4-AcO-MiPT is not fully understood, but it is believed to act as a serotonin receptor agonist, specifically at the 5-HT2A receptor, which is responsible for visual and auditory perception. It may also affect the 5-HT1A receptor, responsible for mood regulation, and other serotonin receptors, contributing to its psychoactive properties.

Safety: As with any psychoactive substance, 4-AcO-MiPT carries potential risks and safety concerns. First, it is essential to purchase this product from trusted sources to ensure purity, as adulterated substances can be dangerous or even fatal. Second, it is advisable to start with low dosage and proceed with caution to avoid complications or overdose. Third, do not mix 4-AcO-MiPT with other drugs or alcohol, as it may enhance the side effects or increase the risk of the negative impact. Fourth, this product can trigger latent psychiatric or neurological conditions, so it is not suitable for people with such conditions or a family history of mental illness. Finally, safe use of 4-AcO-MiPT requires adequate preparation, a comfortable setting, and a sober and responsible companion.

Side effects: The side effects of 4-AcO-MiPT may vary depending on the dosage, the individual, and the context. Some of the potential side effects are:

  1. Nausea
  2. Vomiting
  3. Diarrhea
  4. Headaches
  5. Dizziness
  6. Anxiety
  7. Paranoia
  8. Panic attacks
  9. Delusions
  10. Visual or auditory distortion

Dosing information: The appropriate dosage of 4-AcO-MiPT depends on various factors, such as body weight, tolerance, experience, and personal preferences. However, it is advisable to start with a low dose of 5-10 mg and increase gradually if necessary. A moderate dose ranges from 10-20 mg, while a strong dose is 20-30 mg or higher. However, exceeding the recommended dose can cause severe physical and psychological harm, so use it with caution.

Conclusion: 

4-AcO-MiPT is a potent and popular psychedelic substance that has intense visual and auditory effects. It is a prodrug of the psychoactive substance named MiPT and acts as a serotonin receptor agonist. However, it carries risks and safety concerns and should be used with extreme caution. While some users claim it has therapeutic value, there is no scientific evidence to support such claims. Therefore, the most significant benefit of 4-AcO-MiPT may be recreational enjoyment, but it should only be used by knowledgeable and responsible individuals with proper preparation and understanding of the potential risks.ntal study only
Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code